17 results
8-K
EX-3.1
BAX
Baxter International Inc.
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
as of the last day on which an Access Proposal may be delivered
-9-
pursuant to clause (A) of this Section 4(f) (the “Final Proxy Access Nomination Date … or more vacancies for any reason occurs on the Board of Directors at any time after the Final Proxy Access Nomination Date and before the date
8-K
EX-3.2
BAX
Baxter International Inc.
6 May 22
Material Modifications to Rights of Security Holders
4:57pm
as of the last day on which an Access Proposal may be delivered
-9-
pursuant to clause (A) of this Section 4(f) (the “Final Proxy Access Nomination Date … that one or more vacancies for any reason occurs on the Board of Directors at any time after the Final Proxy Access Nomination Date and before the date
S-3ASR
mm84v82x541
29 Jul 21
Automatic shelf registration
8:27am
8-K
EX-99.1
pvpkvwfb5 ww
28 Sep 20
Regulation FD Disclosure
8:42am
8-K
EX-99.1
i86op
21 Apr 20
Regulation FD Disclosure
6:07am
424B2
mqjt5y z2
14 May 19
Prospectus for primary offering
4:02pm
424B5
9gjtr
10 May 19
Prospectus supplement for primary offering
6:10am
8-K
EX-3.1
lpbdc5n rkjfiyru
15 Nov 18
Departure of Directors or Certain Officers
4:53pm
- Prev
- 1
- Next